GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » Earnings per Share (Diluted)

Yunkang Group (HKSE:02325) Earnings per Share (Diluted) : HK$-1.42 (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group Earnings per Share (Diluted)?

Yunkang Group's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was HK$-1.20. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-1.42.

Yunkang Group's EPS (Basic) for the six months ended in Dec. 2024 was HK$-1.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-1.42.

Yunkang Group's EPS without NRI for the six months ended in Dec. 2024 was HK$-0.55. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.70.


Yunkang Group Earnings per Share (Diluted) Historical Data

The historical data trend for Yunkang Group's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group Earnings per Share (Diluted) Chart

Yunkang Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Earnings per Share (Diluted)
Get a 7-Day Free Trial 0.49 0.76 0.74 -0.19 -1.42

Yunkang Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.25 0.09 -0.27 -0.23 -1.20

Competitive Comparison of Yunkang Group's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, Yunkang Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunkang Group's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Yunkang Group's PE Ratio falls into.


;
;

Yunkang Group Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Yunkang Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-845.257-0)/595.863
=-1.42

Yunkang Group's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (Q: Dec. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-710.592-0)/591.124
=-1.20

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Yunkang Group  (HKSE:02325) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Yunkang Group Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Yunkang Group's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunkang Group Business Description

Traded in Other Exchanges
N/A
Address
Yayingshi Road, No. 9, Science City, Huangpu District, Guangzhou, CHN
Yunkang Group Ltd is a medical operation service provider in China. The company is focusing on the health needs of customers, providing competitive solutions, and other services. The company has three business lines, namely diagnostic testing services for medical consortia, diagnostic outsourcing services, and diagnostic testing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Kastle Limited 2301 Trustee
Yk Innovation Limited 2301 Trustee
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group Headlines

No Headlines